Loading asset research
Connect Biopharma Holdings Limited Ordinary Shares
CNTBNasdaq · USD · StocksQuote as of · Exchange session not verified$2.04
-0.97%
Today
CNTB
Loading 1D prices…
Market cap
$128.5M
Volume
874.5K
52w high
$3.8252w low
$1.23Company profile
Connect Biopharma Holdings Limited Ordinary Shares
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
San Diego, CA, United States
Employees
64
Fiscal year end
1231
CIK
1835268
Session & valuation
Open$2.07
Previous close$2.06
Day high$2.10
Day low$1.94
30-day avg. volume809.6K
Outstanding shares63M
Diluted EPS-$1.00
Latest annual period
P/E (trailing)-2.04
P/E (forward)-2.73
Price / book4.78
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| KZIAKazia Therapeutics Limited American Depositary Shares | $127.9M | — | — | -$18.90 | +1.63% | Buy |
| INOInovio Pharmaceuticals Inc. Common Stock | $129.2M | $65.3K | -130082.79% | -$1.81 | -2.73% | Buy |
| VTVTvTv Therapeutics Inc. Class A Common Stock | $126.4M | $0.00 | — | -$3.20 | +0.35% | Buy |
| HURATuHURA Biosciences Inc. Common Stock | $130.6M | $0.00 | — | -$0.63 | +1.23% | Buy |
| BMEABiomea Fusion Inc. Common Stock | $125.8M | $0.00 | — | -$1.18 | +2.35% | Buy |